Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
NCT03310281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2018-11-21
Summary
The purpose of this study is to evaluate the effects of videogame-like digital therapies as adjunct therapy to antidepressant medications on cognitive deficits associated with major depressive disorder.
Conditions
Interventions
- DEVICE
-
HOLD: Videogame
Videogame-like digital therapy
Sponsors & Collaborators
-
Akili Interactive Labs, Inc.
lead INDUSTRY
Principal Investigators
-
Richard Keefe, PhD · Duke Institute for Brain Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-04
- Primary Completion
- 2018-11-14
- Completion
- 2018-11-14
Countries
- United States
Study Locations
More Related Trials
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
NCT04532749 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
NCT04533529 ·Status: COMPLETED ·Phase: PHASE3
-
Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
NCT02185131 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
NCT00179257 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Treatment of Pediatric MDD to Increase Remission and Prevent Relapse
NCT00612313 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
NCT06559306 ·Status: RECRUITING ·Phase: PHASE3
-
STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
NCT00369746 ·Status: COMPLETED
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
NCT01001559 ·Status: COMPLETED
-
Prevention of Recurrence in Depression With Drugs and CT
NCT00057577 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
NCT00001483 ·Status: COMPLETED ·Phase: PHASE2
-
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
NCT05892744 ·Status: RECRUITING ·Phase: PHASE4
-
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376 ·Status: COMPLETED ·Phase: NA
-
Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
NCT01488266 ·Status: UNKNOWN ·Phase: NA
-
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
NCT00794040 ·Status: COMPLETED ·Phase: PHASE2
-
Lamotrigine in Treatment Resistant Depression in Adolescents
NCT00284791 ·Status: TERMINATED ·Phase: NA
-
Tracking Response to Antidepressants in Advance of Investigational Trials
NCT04748276 ·Status: UNKNOWN
-
Efficacy of Statins Among Major Depressive Disorder
NCT06698666 ·Status: RECRUITING ·Phase: PHASE3
-
Intensive Accelerated iTBS for the Treatment-Resistant Depression
NCT06166082 ·Status: COMPLETED ·Phase: NA
-
TRIAD - Treatment of Insomnia and Depression
NCT00767624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
NCT00095758 ·Status: COMPLETED ·Phase: PHASE3
-
Thyroid Medication and Antidepressants for Treating Major Depression
NCT00208702 ·Status: COMPLETED ·Phase: PHASE4
-
Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
NCT03435744 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
NCT02943577 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4